Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
The following section summarizes insights on Sunshine Biopharma Inc's Quick Ratio:
We've identified the following companies as similar to Sunshine Biopharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Quick Ratio in the popular category include:
A ratio used to assess a company's short-term liquidity.
Quick Ratio or acid-test or liquidity ratio measures the ability of a company to use its near cash or quick assets to extinguish or retire its current liabilities immediately. Quick Ratio is defined as:
(Cash & ST Investments
(+) Accounts Receivable)
(/) Current Liabilities
(=) Quick Ratio
Quick Ratio for Sunshine Biopharma is calculated as follows:
(Cash & ST Investments [ NA ]
(+) Accounts Receivable [ NA ]
(/) Current Liabilities [ NA ]
(=) Quick Ratio [ 3.4x ]
The tables below summarizes the trend in Sunshine Biopharma’s quick ratio over the last five years:
Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
---|---|---|---|---|
2019-12-31 | NA | NA | NA | 0.1x |
2020-12-31 | NA | NA | NA | 1.0x |
2021-12-31 | NA | NA | NA | 22.6x |
2022-12-31 | NA | NA | NA | 3.4x |
2023-12-31 | NA | NA | NA | 3.4x |
The tables below summarizes the trend in Sunshine Biopharma’s quick ratio over the last four quarters:
Fiscal Year | Cash & ST Investments | Accounts Receivable | Current Liabilities | Quick Ratio |
---|---|---|---|---|
2023-12-31 | NA | NA | NA | 3.4x |
2024-03-31 | NA | NA | NA | 3.1x |
2024-06-30 | NA | NA | NA | 2.9x |
2024-09-30 | NA | NA | NA | 3.4x |
Read more on Wikipedia: Quick Ratio
The chart above depicts the distribution of Quick Ratio for companies operating in the Healthcare Sector in the Developed economic region. Over 2,470 companies were considered in this analysis, and 2,376 had meaningful values. The average Quick Ratio of companies in the Sector is 3.2x with a standard deviation of 4.2x. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Sunshine Biopharma Inc's Quick Ratio of 3.4x ranks in the 71.4% percentile for the Sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,474 |
Included Constituents | 2,376 |
Min | 0.0x |
Max | 24.4x |
Median | 1.5x |
Mean | 3.2x |
Standard Deviation | 4.2x |
You can find companies with similar Quick Ratio using this stock screener.